Efficacy and tolerability of antiepileptic drugs in an Omani epileptic population

Yolande Hanssens, Abdullah Al Asmi, Intisar Al Busaidi, Dirk Deleu

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Objective: The aim of this hospital-based study is to get an insight into the efficacy and tolerability of antiepileptic drugs (AED) in Omani epileptic patients. Patients and methods: All Omani patients (aged 14 years and above) suffering from epileptic seizures for at least 2 years and followed-up by board-certified neurologists in Sultan Qaboos University Hospital (SQUH) were evaluated. The treatment retention rate since first visit at SQUH and over the last 2 years was used as primary efficacy measure of AED therapy. Change in seizure-frequency and side effect profiles were also assessed. Results: In this population of 203 confirmed epileptic patients, generalized tonic-clonic (40%) and partial seizures (39%) were most commonly observed, idiopathic/cryptogenic origin (81%) being the most frequent encountered origin. Sixty one percent of the patients were controlled with an AED in monotherapy and overall 34% of patients could be successfully maintained on monotherapy during the whole follow-up period at SQUH (median 6 years). The treatment retention rates for carbamazepine (CBZ) at a daily dose of 400-600 mg, sodium valproate (VPA) at a daily dose of 500-1000 mg, and phenytoin (PHT) at a daily dose of 300 mg, in monotherapy over the total follow-up period was 51, 50, and 21%, respectively. In contrast, over the last 2 years these rates were highest for VPA (91%) followed by CBZ (83%) and PHT (73%). Adverse drug reactions were recorded in 67% of patients, and were most commonly encountered with VPA. Conclusions: Despite a higher adverse effect profile for VPA, long-term treatment with CBZ and VPA appeared to be equally effective in terms of treatment retention rates and seizure control.

Original languageEnglish
Pages (from-to)532-538
Number of pages7
JournalClinical Neurology and Neurosurgery
Volume108
Issue number6
DOIs
Publication statusPublished - Sep 2006

Fingerprint

Anticonvulsants
Valproic Acid
Carbamazepine
Population
Seizures
Phenytoin
Therapeutics
Drug-Related Side Effects and Adverse Reactions
Epilepsy
Drug Therapy
Sultan

Keywords

  • Antiepileptic drugs
  • Efficacy
  • Epilepsy
  • Oman
  • Seizures
  • Tolerability

ASJC Scopus subject areas

  • Clinical Neurology
  • Surgery
  • Neurology

Cite this

Efficacy and tolerability of antiepileptic drugs in an Omani epileptic population. / Hanssens, Yolande; Asmi, Abdullah Al; Busaidi, Intisar Al; Deleu, Dirk.

In: Clinical Neurology and Neurosurgery, Vol. 108, No. 6, 09.2006, p. 532-538.

Research output: Contribution to journalArticle

Hanssens, Yolande ; Asmi, Abdullah Al ; Busaidi, Intisar Al ; Deleu, Dirk. / Efficacy and tolerability of antiepileptic drugs in an Omani epileptic population. In: Clinical Neurology and Neurosurgery. 2006 ; Vol. 108, No. 6. pp. 532-538.
@article{fe74a3cd5a06417ba450f6a0a5bf2873,
title = "Efficacy and tolerability of antiepileptic drugs in an Omani epileptic population",
abstract = "Objective: The aim of this hospital-based study is to get an insight into the efficacy and tolerability of antiepileptic drugs (AED) in Omani epileptic patients. Patients and methods: All Omani patients (aged 14 years and above) suffering from epileptic seizures for at least 2 years and followed-up by board-certified neurologists in Sultan Qaboos University Hospital (SQUH) were evaluated. The treatment retention rate since first visit at SQUH and over the last 2 years was used as primary efficacy measure of AED therapy. Change in seizure-frequency and side effect profiles were also assessed. Results: In this population of 203 confirmed epileptic patients, generalized tonic-clonic (40{\%}) and partial seizures (39{\%}) were most commonly observed, idiopathic/cryptogenic origin (81{\%}) being the most frequent encountered origin. Sixty one percent of the patients were controlled with an AED in monotherapy and overall 34{\%} of patients could be successfully maintained on monotherapy during the whole follow-up period at SQUH (median 6 years). The treatment retention rates for carbamazepine (CBZ) at a daily dose of 400-600 mg, sodium valproate (VPA) at a daily dose of 500-1000 mg, and phenytoin (PHT) at a daily dose of 300 mg, in monotherapy over the total follow-up period was 51, 50, and 21{\%}, respectively. In contrast, over the last 2 years these rates were highest for VPA (91{\%}) followed by CBZ (83{\%}) and PHT (73{\%}). Adverse drug reactions were recorded in 67{\%} of patients, and were most commonly encountered with VPA. Conclusions: Despite a higher adverse effect profile for VPA, long-term treatment with CBZ and VPA appeared to be equally effective in terms of treatment retention rates and seizure control.",
keywords = "Antiepileptic drugs, Efficacy, Epilepsy, Oman, Seizures, Tolerability",
author = "Yolande Hanssens and Asmi, {Abdullah Al} and Busaidi, {Intisar Al} and Dirk Deleu",
year = "2006",
month = "9",
doi = "10.1016/j.clineuro.2005.08.007",
language = "English",
volume = "108",
pages = "532--538",
journal = "Clinical Neurology and Neurosurgery",
issn = "0303-8467",
publisher = "Elsevier",
number = "6",

}

TY - JOUR

T1 - Efficacy and tolerability of antiepileptic drugs in an Omani epileptic population

AU - Hanssens, Yolande

AU - Asmi, Abdullah Al

AU - Busaidi, Intisar Al

AU - Deleu, Dirk

PY - 2006/9

Y1 - 2006/9

N2 - Objective: The aim of this hospital-based study is to get an insight into the efficacy and tolerability of antiepileptic drugs (AED) in Omani epileptic patients. Patients and methods: All Omani patients (aged 14 years and above) suffering from epileptic seizures for at least 2 years and followed-up by board-certified neurologists in Sultan Qaboos University Hospital (SQUH) were evaluated. The treatment retention rate since first visit at SQUH and over the last 2 years was used as primary efficacy measure of AED therapy. Change in seizure-frequency and side effect profiles were also assessed. Results: In this population of 203 confirmed epileptic patients, generalized tonic-clonic (40%) and partial seizures (39%) were most commonly observed, idiopathic/cryptogenic origin (81%) being the most frequent encountered origin. Sixty one percent of the patients were controlled with an AED in monotherapy and overall 34% of patients could be successfully maintained on monotherapy during the whole follow-up period at SQUH (median 6 years). The treatment retention rates for carbamazepine (CBZ) at a daily dose of 400-600 mg, sodium valproate (VPA) at a daily dose of 500-1000 mg, and phenytoin (PHT) at a daily dose of 300 mg, in monotherapy over the total follow-up period was 51, 50, and 21%, respectively. In contrast, over the last 2 years these rates were highest for VPA (91%) followed by CBZ (83%) and PHT (73%). Adverse drug reactions were recorded in 67% of patients, and were most commonly encountered with VPA. Conclusions: Despite a higher adverse effect profile for VPA, long-term treatment with CBZ and VPA appeared to be equally effective in terms of treatment retention rates and seizure control.

AB - Objective: The aim of this hospital-based study is to get an insight into the efficacy and tolerability of antiepileptic drugs (AED) in Omani epileptic patients. Patients and methods: All Omani patients (aged 14 years and above) suffering from epileptic seizures for at least 2 years and followed-up by board-certified neurologists in Sultan Qaboos University Hospital (SQUH) were evaluated. The treatment retention rate since first visit at SQUH and over the last 2 years was used as primary efficacy measure of AED therapy. Change in seizure-frequency and side effect profiles were also assessed. Results: In this population of 203 confirmed epileptic patients, generalized tonic-clonic (40%) and partial seizures (39%) were most commonly observed, idiopathic/cryptogenic origin (81%) being the most frequent encountered origin. Sixty one percent of the patients were controlled with an AED in monotherapy and overall 34% of patients could be successfully maintained on monotherapy during the whole follow-up period at SQUH (median 6 years). The treatment retention rates for carbamazepine (CBZ) at a daily dose of 400-600 mg, sodium valproate (VPA) at a daily dose of 500-1000 mg, and phenytoin (PHT) at a daily dose of 300 mg, in monotherapy over the total follow-up period was 51, 50, and 21%, respectively. In contrast, over the last 2 years these rates were highest for VPA (91%) followed by CBZ (83%) and PHT (73%). Adverse drug reactions were recorded in 67% of patients, and were most commonly encountered with VPA. Conclusions: Despite a higher adverse effect profile for VPA, long-term treatment with CBZ and VPA appeared to be equally effective in terms of treatment retention rates and seizure control.

KW - Antiepileptic drugs

KW - Efficacy

KW - Epilepsy

KW - Oman

KW - Seizures

KW - Tolerability

UR - http://www.scopus.com/inward/record.url?scp=33746911214&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33746911214&partnerID=8YFLogxK

U2 - 10.1016/j.clineuro.2005.08.007

DO - 10.1016/j.clineuro.2005.08.007

M3 - Article

VL - 108

SP - 532

EP - 538

JO - Clinical Neurology and Neurosurgery

JF - Clinical Neurology and Neurosurgery

SN - 0303-8467

IS - 6

ER -